Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.
2.
3.

Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery.

Matsumoto T, Wakabayashi K, Kobayashi T, Kamata K.

Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1064-71. Epub 2004 May 6.

4.

Cytosolic protein kinase A mediates the growth hormone (GH)-releasing action of GH-releasing factor in purified rat somatotrophs.

Wong AO, Moor BC, Hawkins CE, Narayanan N, Kraicer J.

Neuroendocrinology. 1995 May;61(5):590-600.

PMID:
7617138
6.

Modulation of regulatory and catalytic subunit levels of cAMP-dependent protein kinase A in anterior pituitary cells in response to direct activation of protein kinases A and C or after GnRH stimulation.

Garrel G, Delahaye R, Hemmings BA, Counis R.

Neuroendocrinology. 1995 Nov;62(5):514-22. Erratum in: Neuroendocrinology 1996 Feb;63(2):187.

PMID:
8559283
7.

Hormonal regulation of adenosine 3',5'-monophosphate-dependent protein kinase.

Corbin JD, Keely SL, Soderling TR, Park CR.

Adv Cyclic Nucleotide Res. 1975;5:265-79.

PMID:
165670
8.

Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension.

Silver PJ, Michalak RJ, Kocmund SM.

J Pharmacol Exp Ther. 1985 Mar;232(3):595-601.

PMID:
2983064
9.

Protein kinase A: regulation and receptor-mediated delivery of antisense oligonucleotides and cytotoxic drugs.

Sveshnikov PG, Grozdova ID, Nesterova MV, Severin ES.

Ann N Y Acad Sci. 2002 Jun;968:158-72. Review.

PMID:
12119275
10.

Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism.

Ma Y, Pitson S, Hercus T, Murphy J, Lopez A, Woodcock J.

J Biol Chem. 2005 Jul 15;280(28):26011-7. Epub 2005 May 9.

11.

Endoplasmic reticulum contribution to the relaxant effect of cGMP- and cAMP-elevating agents in feline aorta.

Mundiña-Weilenmann C, Vittone L, Rinaldi G, Said M, de Cingolani GC, Mattiazzi A.

Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H1856-65.

12.

Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.

Butt E, Pöhler D, Genieser HG, Huggins JP, Bucher B.

Br J Pharmacol. 1995 Dec;116(8):3110-6.

13.

A non-radioactive assay for the cAMP-dependent protein kinase activity in rat brain homogenates and age-related changes in hippocampus and cortex.

Karege F, Schwald M, Lambercy C, Murama JJ, Cisse M, Malafosse A.

Brain Res. 2001 Jun 8;903(1-2):86-93.

PMID:
11382391
14.

Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists.

Brizzolara-Gourdie A, Webb JG.

J Pharmacol Exp Ther. 1997 Apr;281(1):354-9.

15.
16.

Cyclic AMP-mediated induction of the glial fibrillary acidic protein is independent of protein kinase A activation in rat C6 glioma.

Anciaux K, Van Dommelen K, Nicolai S, Van Mechelen E, Slegers H.

J Neurosci Res. 1997 May 15;48(4):324-33.

PMID:
9169858
17.

Compartmentation of the type I regulatory subunit of cAMP-dependent protein kinase in cardiac ventricular muscle.

Reinitz CA, Bianco RA, Shabb JB.

Arch Biochem Biophys. 1997 Dec 15;348(2):391-402.

PMID:
9434753
18.

Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin.

de Piña MZ, Vázquez-Meza H, Pardo JP, Rendón JL, Villalobos-Molina R, Riveros-Rosas H, Piña E.

J Biol Chem. 2008 May 2;283(18):12373-86. doi: 10.1074/jbc.M706832200. Epub 2008 Mar 6.

19.
20.

A comparison of the effects of forskolin and nitroprusside on cyclic nucleotides and relaxation in the rat aorta.

Lincoln TM, Fisher-Simpson V.

Eur J Pharmacol. 1984 May 18;101(1-2):17-27.

PMID:
6086362

Supplemental Content

Support Center